ICR responds to NICE approval of palbociclib for treating advanced breast cancer after hormone therapy 28 Nov 2019 The Institute of Cancer Research, London, welcomes the approval by NICE of the innovative targeted cancer treatment palbociclib for women with advanced breast cancer who have already received hormone therapy. Find out more Show/Hide
Manifesto calls for action on cancer drug access as survey shows patient delays 24 Apr 2019 Our new 10-point manifesto is calling for action to speed up access to innovative cancer drugs as an accompanying survey of 1,000 cancer patients finds many face barriers in receiving the latest treatments. Find out more Show/Hide
Public-private sector collaboration the theme as Minister visits The London Cancer Hub 15 Nov 2018 Business Minister Lord Henley has visited The London Cancer Hub to discuss new opportunities for life-sciences businesses to collaborate with world-leading scientists from The Institute of Cancer Research (ICR), London. Find out more Show/Hide
Experts call for genetic testing to personalise treatment for all children assessed for new cancer treatments 26 Sep 2018